Next |
home / stock / nvus / nvus message board
Subject | By | Source | When |
---|---|---|---|
$NVUS buy 0.99 | stocktrademan | investorshub | 09/23/2020 1:07:18 PM |
* * $NVUS Video Chart 09-15-2020 * * | ClayTrader | investorshub | 09/15/2020 9:34:51 PM |
Huge gains today. Got a order in at | hedge_fun | investorshub | 09/15/2020 2:52:43 PM |
bounced today $1.10 | wesley_ | investorshub | 09/15/2020 2:40:38 PM |
There it is! | beebread | investorshub | 07/21/2020 8:41:36 PM |
ReversAl in progress | beebread | investorshub | 07/09/2020 11:24:39 PM |
look at that chart, primed for a bounce | beebread | investorshub | 06/15/2020 8:11:13 PM |
Adding here | beebread | investorshub | 06/13/2020 12:46:51 AM |
Ouch for the people who didnt sell last | anthjr87 | investorshub | 06/01/2020 6:33:01 PM |
* * $NVUS Video Chart 05-14-2020 * * | ClayTrader | investorshub | 05/14/2020 10:11:17 PM |
$1.15 :-D | wesley_ | investorshub | 05/14/2020 2:52:52 PM |
If you saw this a few weeks ago, | swingingRichard | investorshub | 05/14/2020 3:22:42 AM |
* * $NVUS Video Chart 05-13-2020 * * | ClayTrader | investorshub | 05/13/2020 8:26:57 PM |
$.70 lovely :-) | wesley_ | investorshub | 04/22/2020 1:32:41 PM |
$.55 nice | wesley_ | investorshub | 04/21/2020 6:30:05 PM |
* * $NVUS Video Chart 01-30-2020 * * | ClayTrader | investorshub | 01/30/2020 10:56:51 PM |
* * $NVUS Video Chart 12-10-2019 * * | ClayTrader | investorshub | 12/10/2019 10:49:56 PM |
Got 0,60s | europtiger | investorshub | 12/10/2019 7:31:09 PM |
$NVUS BREAKOUT IMMINENT IN Novus Therapeutics, VOLUME SPIKES | TFMG | investorshub | 05/24/2019 11:30:38 PM |
Bad news. | willlbone | investorshub | 04/22/2019 7:05:55 PM |
News, Short Squeeze, Breakout and More Instantly...
Novus Therapeutics Inc. Company Name:
NVUS Stock Symbol:
NASDAQ Market:
Novus Therapeutics Inc. Website:
Eledon to commence trading on the Nasdaq exchange under the ticker “ELDN” effective tomorrow, January 5, 2021 Eledon is well financed to complete up to four Phase 2 clinical trials of lead candidate AT-1501, a potential best in class anti-CD40L monoclonal antibody ...
IRVINE, Calif., Dec. 22, 2020 (GLOBE NEWSWIRE) -- Novus Therapeutics, Inc. (“Novus”) (NASDAQ: NVUS), a clinical stage biopharmaceutical company focused on developing life-changing, targeted medicines for patients undergoing organ or cellular transplantation, as well as those l...
Former Chief Development and Chief Operating Officer of MyoKardia, Inc. brings extensive clinical development expertise as Novus prepares to conduct up to four Phase 2 clinical trials Novus Therapeutics, Inc. (“Novus”) (NASDAQ: NVUS), a clinical stage biopharma...